
Rashid K. Sayyid, MD, MSc, discusses the role of combination therapy in metastatic castrate-resistant prostate cancer.

Rashid K. Sayyid, MD, MSc, discusses the role of combination therapy in metastatic castrate-resistant prostate cancer.

Rashid K. Sayyid, MD, MSc, gives a brief overview of treatment options for nonmetastatic castrate-resistant prostate cancer.

Expert perspectives on the treatment approach for patients with metastatic castrate-resistant prostate cancer.

An expert on prostate cancer gives a brief overview of castrate-resistant prostate cancer.

A urologic oncology fellow provides a comprehensive overview of systemic therapy options for patients with prostate cancer.

Rashid K. Sayyid, MD, MSc, describes the staging and risk stratification process for patients with prostate cancer and their effect on prognosis.

Published: October 19th 2023 | Updated:

Published: October 5th 2023 | Updated:

Published: October 19th 2023 | Updated:

Published: September 21st 2023 | Updated:

Published: October 19th 2023 | Updated:

Published: October 26th 2023 | Updated: